Glenmark Pharmaceuticals Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Glenmark Pharmaceuticals has uploaded the audio recording of its Q1 FY 2026-27 earnings call on its website.
BSE & NSE corporate filings with AI summaries
Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals has uploaded the audio recording of its Q1 FY 2026-27 earnings call on its website.
GPT Infraprojects Limited
GPT Infraprojects Limited has informed the Exchange about the link to the recording of a conference call with investors to discuss the company's financial performance for the 1st quarter ended June 30, 2026.
Nahar Spinning Mills Limited
Nahar Spinning Mills Limited has informed the Exchange regarding 'DEMAT REPORT FOR THE MONTH OF JULY,2026'. The company has dematerialized 2333 equity shares in the month of July, 2026, and the total holding of National Securities Depository ltd. (NSDL) and Central Depository Services Ltd. (CDSL) is 35673453 equity shares.
Tata Chemicals Limited
Tata Chemicals Limited has announced the transcript of its Q1FY27 earnings conference call, highlighting the company's operational highlights and demand scenario across its three segments: Living, Industry, and Farm Essentials. The company has made a significant accounting change, renaming its segments to align with its business operations.
Restaurant Brands Asia Limited
Restaurant Brands Asia Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and has also approved an investment in its subsidiary PT Sari Burger Indonesia.
Peninsula Land Limited
Peninsula Land Limited has informed the Exchange about Copy of Newspaper Publication regarding the 115th Annual General Meeting to be held through Video Conference (VC) or Other Audio Visual Means (OAVM) on August 3, 2022, and the publication of the notice in the newspaper as required by Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Raymond Limited
Raymond Limited has announced a conference call to discuss its financial performance for the first quarter ended June 30, 2026, scheduled for August 7, 2026.
Syrma SGS Technology Limited
Syrma SGS Technology Limited has released its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, as per Regulation 34(2)(f) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report covers the company's sustainability and social responsibility initiatives, including its operations, markets served, employees, and environmental impact.
Sical Logistics Limited
Sical Logistics Limited has informed the Exchange regarding Notice of Postal Ballot for approval of material related party transactions and creation of mortgage on land and building of a step-down subsidiary.
Kaya Limited
Kaya Limited has submitted its financial results for the quarter ended June 30, 2026, along with a limited review report from its statutory auditor. The company has also made several appointments, including a new Company Secretary and Compliance Officer, a Vice President and HR-Head, and a Managing Director. Additionally, the Board has deferred the agenda item for raising equity shares and debt securities until further notice.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has announced its unaudited standalone and consolidated financial results for the first quarter ended 30th June 2026, along with the re-appointment of Mr. Bhushan Akshikar as Managing Director and the appointment of Ms. Karine J F Natland as Non-Executive Director.
Kirloskar Pneumatic Company Limited
Kirloskar Pneumatic Company Limited has acquired 99.49% of the total voting power of Kirloskar South East Asia Co. Limited ('KSEA') at a total consideration of 1,70,52,750 THB paid in cash equivalent to Rs. 4,94,52,975/-, making KSEA a subsidiary of the company as per the Companies Act, 2013.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has announced its Q1 FY27 financial results, with revenue up 15% YoY to INR 924 crores and PAT increasing by 24% to INR 253 crores. The company's General Medicines portfolio grew strongly, with key promoted brands outperforming the market. The company has also made progress in strengthening its supply chain resilience and is preparing for key pipeline launches.
Kansai Nerolac Paints Limited
Kansai Nerolac Paints Limited has informed the Exchange regarding a press release dated August 03, 2026, titled "Press Release for the unaudited financial results for the quarter ended 30th June, 2026." The Board of Directors of Kansai Nerolac Paints Limited has considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2026.
TCPL Packaging Limited
TCPL Packaging Limited has scheduled a conference call on August 12, 2026, to discuss its Q1 FY2027 results, which will be declared on August 11, 2026.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the quarter ended June 30, 2026, along with changes in management and other business updates.
IL&FS Engineering and Construction Company Limited
IL&FS Engineering and Construction Company Limited has published unaudited standalone and consolidated financial results for the quarter ended 30th June, 2026, and Hinduja Housing Finance Limited has taken possession of two properties due to non-payment of loans.
Computer Age Management Services Limited
Computer Age Management Services Limited has informed the Exchange about Investor Presentation, presenting Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026, with EBITDA growing 18.3% Y-o-Y to ₹183 Cr. and PAT growing 17.3% Y-o-Y to ₹128 Cr.
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has presented its investor presentation, highlighting its Q1 FY27 financial performance, which saw revenue growth of 15% and EBITDA margin expansion of 50 bps, driven by execution excellence and portfolio transformation. The company's key brands maintained their competitive performance, and the vaccine segment continues to lead the market.
Madhya Bharat Agro Products Limited
Madhya Bharat Agro Products Limited has informed the Exchange about Copy of Newspaper Publication regarding Extra-Ordinary General Meeting (EGM) and E-voting information.